Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker

Aaron Jones Gifty SS; Senthilvelan M; Baburaj K; Manojkumar V; Bhuvaneshwari V

doi:10.22271/27069567.2021.v3.i2g.291

2021, Vol. 3, Issue 2, Part G

Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker

Author(s): Aaron Jones Gifty SS, Senthilvelan M, Baburaj K, Manojkumar V and Bhuvaneshwari V

Abstract: Background: Acute Coronary Syndrome is a big burden in India due to urbanization and economic transition. Risk stratification in the emergency room is important for initiating appropriate therapy. Acute Coronary Syndrome has an inflammatory process due to atherosclerosis in which platelets are elevated and lymphocytes are reduced. Earlier studies have tried using Platelet Lymphocyte Ratio in determining the severity of the Acute Coronary event.

Objective: This study aims is to use Platelet Lymphocyte Ratio in Acute Coronary Syndrome as a marker of prognosis.

Methods: We conducted a single centre cross-sectional study of 100 random patients with Acute Coronary Syndrome during the study period from November 2019 to October 2021.

Results: There was a statistically significant (p=0.0001) correlation between Platelet Lymphocyte Ratio and GRACE score, TIMI score in Acute Coronary Syndrome.

Conclusion: Platelet Lymphocyte Ratio can be used as a prognostic marker in Acute Coronary Syndrome.

DOI: 10.22271/27069567.2021.v3.i2g.291

Pages: 445-451 | Views: 595 | Downloads: 232

Download Full Article: Click Here

How to cite this article:

Aaron Jones Gifty SS, Senthilvelan M, Baburaj K, Manojkumar V, Bhuvaneshwari V. Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker. Int J Adv Res Med 2021;3(2):445-451. DOI: 10.22271/27069567.2021.v3.i2g.291

2021, Vol. 3, Issue 2, Part G

Study to estimate platelet lymphocyte ratio in acute coronary syndrome as a prognostic marker

Related Links

Related Journal Subscription